✦ LIBER ✦

RNA interference targeting urokinase-type plasminogen activator receptor inhibits tumour growth of oral squamous cell carcinoma in vivo

✍ Scribed by X. Liang; H. Zhou; Y. Tang; X. Yang; J. Yang; G. Zhu; M. Zheng; C. Zhang

Book ID: 116561538
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 90 KB
Volume: 38
Category: Article
ISSN: 0901-5027
DOI: 10.1016/j.ijom.2009.03.479

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RNAi targeting urokinase-type plasminoge

RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma in vivo

✍ Hao Zhou; Yaling Tang; Xinhua Liang; Xiaoqin Yang; Jing Yang; Guiquan Zhu; Min Z 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 809 KB

## Abstract It has been admitted that urokinase‐type plasminogen activator receptor (u‐PAR) is overexpressed in many human malignant tumors including oral squamous cell carcinoma (OSCC) and plays an important role in a variety of cancer key cellular events as a versatile signaling orchestrator. In

Prognostic value analysis of urokinase-t

Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study

✍ Roberta Bacchiocchi; Corrado Rubini; Elisa Pierpaoli; Giulia Borghetti; Pasquale 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 436 KB

Inhibition of invasion and metastasis in

Inhibition of invasion and metastasis in oral cancer by targeting urokinase-type plasminogen activator receptor

✍ Shinichi Nozaki; Yoshio Endo; Hirokazu Nakahara; Kunio Yoshizawa; Yukari Hashiba 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 364 KB

Clinical relevance of urokinase-type pla

Clinical relevance of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in oral squamous cell carcinoma (OSCC)

✍ H.-F. Zeilhofer; K.P. Bock; P. Dettmar; B. Hundsdorfer; K. Ulm; R. Sader; H.-H. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Gangliosides Inhibit Urokinase-Type Plas

Gangliosides Inhibit Urokinase-Type Plasminogen Activator (uPA)-Dependent Squamous Carcinoma Cell Migration by Preventing uPA Receptor/alpha5beta1 Integrin/Epidermal Growth Factor Receptor Interactions

✍ Wang, Xiao-Qi; Sun, Ping; Paller, Amy S. 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 411 KB

Expression of plasminogen activator inhi

Expression of plasminogen activator inhibitor-1, urokinase receptor and laminin γ-2 chain is an early coordinated event in incipient oral squamous cell carcinoma

✍ Pia Lindberg; Åke Larsson; Boye Schnack Nielsen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 880 KB

## Abstract Cancer cell invasion is facilitated by extracellular matrix degrading proteases such as plasmin. We have studied the expression of plasminogen activator inhibitor‐1 (PAI‐1) and urokinase receptor (uPAR) together with the γ2‐chain of laminin‐5 (lam‐γ2) by immunohistochemistry in 20 cases